Dhanuka Agritech Limited has signed an agreement to acquire international rights to the active ingredients Iprovalicarb and Triadimenol. With this acquisition, Dhanuka plans to expand its footprint in more than 20 countries, including the regions of LATAM, EMEA and Asia including India. These products were invented by Bayer AG.

This acquisition will enable Dhanuka to embark on a journey of global market expansion. Under this acquisition, Dhanuka Agritech Limited will get all the rights for manufacturing and sale of Iprovalicarb and Triadimenol in more than 20 countries. In this transaction, Dhanuka will acquire the global rights to the associated brand Melody (for Iprovalicarb) with sub-brands like Melody Duo, Melody Compact, Melodika and others.

As part of the Agreement, the companies have agreed on a transition plan that allows Dhanuka to provide seamless service, ensuring no disruption for growers and customers globally. Further, Dhanuka will be shifting the manufacturing of at least one of the products to India, leveraging the capabilities of its manufacturing unit at Dahej, Gujarat. Iprovalicarb is a fungicide from the Carboxylic Acid Amines (CAA) class, used for disease management caused by Oomycetes species in Horticulture crops.

Triadimenol is a well-established product used in seed treatment for cereals and cotton as a solo formulation and as a part of multiple treatment seasonal program in coffee as a pre-mix. Triadimenol is a SBI class 1, DMI triazole fungicide to control various diseases. The agreement will strengthen Dhanuka's market position by providing a jump to both the topline and bottom-line by selling its products in India and global markets.